Millennium Management
IOBT

Millennium Management’s IO Biotech IOBT Stock Holding History

Millennium Management’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-194,158
Closed -$11.4K – 6112
2026
Q1 		$11.4K Buy
194,158
+55,442
+40% +$18.9K ﹤0.01% 5531
2025
Q4 		$84.5K Sell
138,716
-1,253,680
-90% -$932K ﹤0.01% 5658
2025
Q3 		$506K Buy
+1,392,396
New +$2.4M ﹤0.01% 5066
2023
Q2 		– Sell
-19,917
Closed -$37K – 6383
2023
Q1 		$37K Sell
19,917
-637
-3% -$1.59K ﹤0.01% 5717
2022
Q4 		$47K Sell
20,554
-17,768
-46% -$47K ﹤0.01% 5793
2022
Q3 		$104K Sell
38,322
-7,909
-17% -$29.3K ﹤0.01% 5947
2022
Q2 		$216K Sell
46,231
-26,497
-36% -$162K ﹤0.01% 5593
2022
Q1 		$385K Sell
72,728
-5,235
-7% -$34.6K ﹤0.01% 5327
2021
Q4 		$512K Buy
+77,963
New +$753K ﹤0.01% 5021

Millennium Management's IOBT Position: Q2 2026 in Review

Millennium Management sold out of IO Biotech (IOBT) in Q2 2026, closing a stake of 194,158 shares — an estimated $11.4K sold.

Millennium Management first reported a position in IOBT in Q4 2021 and held it in 9 quarters. The position peaked at $512K in Q4 2021. 0 funds tracked by Wall St. Rank hold IOBT as of Q2 2026.

  • Millennium Management reported no remaining IO Biotech position as of Q2 2026 after selling out during the quarter.
  • Millennium Management sold 194,158 IO Biotech shares in Q2 2026, an estimated $11.4K.
  • Millennium Management first reported a position in IO Biotech in Q4 2021 and held it in 9 quarters.
  • Millennium Management's IO Biotech position peaked at $512K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held IO Biotech as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.